[Results of the treatment of trophoblast tumours (author's transl)].
Within 10 years 24 patients were treated for choriocarcinoma. Experience with new methods of diagnosis, treatment and followup was gained. 11 patients were considered to be in a low risk group and 13 patients were categorized as high risk patients. The treatment was primarily conservative. Patients with low risk received single treatment with methotrexate. In some cases in the high-risk group combination chemotherapy or polychemotherapy was used. In addition to the clinical findings, the results of the treatment are monitored with serial beta HCG determinations. Of the 11 patients in the low-risk group all well and free of recurrence. Of the high-risk group 6 patients died. Of the total of 24 patients with choriocarcinoma 18 (75%) are well and free of recurrence.
D006063:Chorionic Gonadotropin / Q000652:urine; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D011247:Pregnancy; D012306:Risk; D014328:Trophoblastic Neoplasms / Q000188:drug therapy* / Q000652:urine; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000652:urine
D006063:Chorionic Gonadotropin; D008727:Methotrexate
Ergebnisse der Behandlung von Trophoblasttumoren.